Abstract
In this study age-, circadian rhythm- and methylphenidate administration- effect on open field habituation and object recognition were analyzed. Young and adult male Wistar rats were treated with saline or methylphenidate 2.0mg/kg for 28 days. Experiments were performed during the light and the dark cycle. Locomotor activity was significantly altered by circadian cycle and methylphenidate treatment during the training session and by drug treatment during the testing session. Exploratory activity was significantly modulated by age during the training session and by age and drug treatment during the testing session. Object recognition memory was altered by cycle at the training session; by age 1.5 h later and by cycle and age 24 h after the training session. These results show that methylphenidate treatment was the major modulator factor on open-field test while cycle and age had an important effect on object recognition experiment.
Keywords: Memory, methylphenidate, locomotor activity, aging, rat behavior, circadian rhythm
Current Neurovascular Research
Title: Chronic Methylphenidate-Effects Over Circadian Cycle of Young and Adult Rats Submitted to Open-Field and Object Recognition Tests
Volume: 6 Issue: 4
Author(s): Karin M. Gomes, Renan P. Souza, Samira S. Valvassori, Gislaine Z. Reus, Cecilia G. Inacio, Marcio R. Martins, Clarissa M. Comim and Joao Quevedo
Affiliation:
Keywords: Memory, methylphenidate, locomotor activity, aging, rat behavior, circadian rhythm
Abstract: In this study age-, circadian rhythm- and methylphenidate administration- effect on open field habituation and object recognition were analyzed. Young and adult male Wistar rats were treated with saline or methylphenidate 2.0mg/kg for 28 days. Experiments were performed during the light and the dark cycle. Locomotor activity was significantly altered by circadian cycle and methylphenidate treatment during the training session and by drug treatment during the testing session. Exploratory activity was significantly modulated by age during the training session and by age and drug treatment during the testing session. Object recognition memory was altered by cycle at the training session; by age 1.5 h later and by cycle and age 24 h after the training session. These results show that methylphenidate treatment was the major modulator factor on open-field test while cycle and age had an important effect on object recognition experiment.
Export Options
About this article
Cite this article as:
Gomes M. Karin, Souza P. Renan, Valvassori S. Samira, Reus Z. Gislaine, Inacio G. Cecilia, Martins R. Marcio, Comim M. Clarissa and Quevedo Joao, Chronic Methylphenidate-Effects Over Circadian Cycle of Young and Adult Rats Submitted to Open-Field and Object Recognition Tests, Current Neurovascular Research 2009; 6 (4) . https://dx.doi.org/10.2174/156720209789630357
DOI https://dx.doi.org/10.2174/156720209789630357 |
Print ISSN 1567-2026 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5739 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Determining Effective Diabetic Care; A Multicentre - Longitudinal Interventional Study
Current Pharmaceutical Design Pleiotropic Effects of Statins - Clinical Evidence
Current Pharmaceutical Design Which Drugs for the Control of Fever in Critical Patients
Current Drug Targets Blood Pressure and Vascular Alterations with Growth in Childhood
Current Pharmaceutical Design New Strategies in Treatment of Mineral and Bone Disorders and Associated Cardiovascular Disease in Patients with Chronic Kidney Disease
Recent Patents on Cardiovascular Drug Discovery Therapeutic Approach for Neuronal Disease by Regulating Reninangiotensin System
Current Hypertension Reviews Monoclonal Antobodies: Application in Radiopharmacy
Current Radiopharmaceuticals Preventing Type 2 Diabetes Mellitus: Room for Residual Risk Reduction After Lifestyle Changes?
Current Pharmaceutical Design The Transcriptional Regulation of the Human CYP2C Genes
Current Drug Metabolism Vitamin D and Cardiovascular Disease
Current Vascular Pharmacology Eicosanoid Inhibitors as Therapeutic Targets for Metabolic Syndrome Related Kidney Disease
Current Enzyme Inhibition Efficacy of Zofenopril Alone or in Combination with Hydrochlorothiazide in Patients with Kidney Dysfunction
Current Clinical Pharmacology Rho-Kinase and RGS-Containing RhoGEFs as Molecular Targets for the Treatment of Erectile Dysfunction
Current Pharmaceutical Design Fibrates and Microvascular Complications in Diabetes - Insight from the FIELD Study
Current Pharmaceutical Design Pro-Stimulatory Role of Methemoglobin in Inflammation Through Hemin Oxidation and Polymerization
Inflammation & Allergy - Drug Targets (Discontinued) Cell Immunity in Coronary Artery Disease (CAD)
Current Immunology Reviews (Discontinued) Menopause and its Cardiometabolic Consequences: Current Perspectives
Current Vascular Pharmacology Metabolic Features of Alcoholic Liver Disease
Reviews on Recent Clinical Trials Complement Components, C3 and C4, and the Metabolic Syndrome
Current Diabetes Reviews Effect of Black Seed on Dextromethorphan O- and N-Demethylation in Human Liver Microsomes and Healthy Human Subjects
Drug Metabolism Letters